Bath & Body Works, Inc. (BBWI)
Quantitative Summary
DeterministicAt 6.0x earnings — a 83% discount to the sector average of 35.0x — BBWI is in the lower valuation range. Financial health is average: Piotroski 5/9, Altman Z 2.3.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency for Bath & Body Works presents a stark dichotomy between operational cash generation and equity structure. The company demonstrates robust fundamental quality with an ROIC of 26.3% significantly exceeding the WACC of 8.9%, creating a +17.4% spread that indicates strong value creation potential from core operations. This is underpinned by healthy gross margins at 43.7% and a Piotroski F-Score of 5/9, suggesting moderate financial strength with no evidence of earnings manipulation given the negative Beneish M-Score of -3.01. However, the DuPont decomposition reveals that reported ROE is severely distorted to -50.7%, driven entirely by an equity multiplier of -3.96x; this negative leverage suggests substantial debt or off-balance-sheet liabilities are inflating total capital while depressing shareholder returns on book value.
Valuation metrics further highlight a significant divergence between market pricing and intrinsic models derived from the provided data. The current P/E ratio of 6.0x stands in sharp contrast to both historical norms and the sector average of 36.4x, implying that the market has priced in severe distress or terminal decline despite the positive ROIC-WACC spread. Conversely, a DCF model suggests an implied fair value of $61, indicating that current equity pricing may be disconnected from projected cash flows if growth assumptions align with historical patterns rather than recent stagnation. The near-flat revenue trajectory of -0.2% YoY complicates this picture, as the market appears to have discounted future expansion entirely while ignoring the underlying operational efficiency metrics.
Risk assessment parameters offer limited directional clarity regarding immediate catalysts or downside protection. Insider activity over the last 90 days remains neutral with zero net flow, providing no clear signal of management confidence or distress selling. While the Altman Z-Score of 2.3 places the firm in a "grey zone" between safety and bankruptcy risk, it does not currently flag imminent insolvency. The combination of extreme valuation compression relative to peers and distorted equity metrics creates an environment where traditional fundamental analysis yields conflicting signals regarding long-term viability versus short-term opportunistic entry points based on mean reversion expectations.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6.9% | 8.9% | 10.9% |
|---|---|---|---|
| 2% | $80 | $53 | $38 |
| 3% | $99 | $61 | $42 |
| 4% | $133 | $73 | $48 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.9%, terminal growth 3%. Fair value $61 (+0.0%). Not investment advice.
Valuation Context
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XRT or VFVA, the fund manager is mechanically forced to buy or sell BBWI shares regardless of Bath & Body Works, Inc.'s individual fundamentals. We estimate $133M of passive capital is structurally linked to BBWI through 8 tracked ETFs. Passive flows have a limited but growing influence on BBWI's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Bath & Body Works, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Bath & Body Works, Inc. (BBWI) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Amazon.com Inc. (AMZN) as the most exposed collateral stock, sharing 1 ETFs with BBWI. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 10 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
BBWI Ownership Dynamics
ETFs with Highest BBWI Exposure
Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
BBWI Capital Efficiency
How efficiently does Bath & Body Works, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Bath & Body Works, Inc. converts 61% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 17.4% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-05 | 21,670 | $18.56 | $402,195.2 |
| 2026-04-08 | 24 | $18.09 | $434.16 |
| 2026-04-06 | 1,121 | $18.57 | $20,816.97 |
| 2026-03-26 | 1,227 | $18.19 | $22,319.13 |
| 2026-02-24 | 4,435 | $22.52 | $99,876.2 |
| 2026-02-17 | 2,937 | $24.07 | $70,693.59 |
| 2026-01-21 | 187,449 | $21.65 | $4.1M |
| 2026-01-05 | 66,831 | $20.74 | $1.4M |
| 2026-01-02 | 1,693 | $20.08 | $33,995.44 |
| 2025-12-29 | 10,509 | $19.79 | $207,973.11 |
| 2025-12-24 | 158 | $19.25 | $3,041.5 |
| 2025-12-22 | 126,120 | $19.79 | $2.5M |
| 2025-12-19 | 129,170 | $19.62 | $2.5M |
| 2025-12-18 | 136,919 | $19.67 | $2.7M |
| 2025-12-12 | 438 | $19.94 | $8,733.72 |
| 2025-12-11 | 4,034 | $19.53 | $78,784.02 |
| 2025-12-02 | 16,305 | $18.98 | $309,468.9 |
| 2025-12-01 | 56,576 | $17.41 | $984,988.16 |
| 2025-11-13 | 266 | $22.40 | $5,958.4 |
| 2025-11-12 | 91 | $21.96 | $1,998.36 |
| 2025-11-10 | 98,859 | $22.91 | $2.3M |
| 2025-10-31 | 920 | $23.93 | $22,015.6 |
| 2025-10-14 | 2,977 | $25.79 | $76,776.83 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare BBWI to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.